Posts by John

New clinical data shows Retatrutide achieves 30% weight loss, rivaling bariatric surgery results. Learn how this triple-agonist drug is changing obesity care.

Novo Nordisk confirms a data breach involving third-party systems, exposing clinical trial patient information. Learn the impact and security response.

New trial data shows EDG-5506 effectively treats hypertrophic cardiomyopathy, offering a potential breakthrough in cardiac myosin inhibition therapy.

New Phase 1 data for HCW9302 suggests promising safety and early activity in treating alopecia areata through targeted IL-2Rα-biased immunotherapy.

Neumora Therapeutics cuts staff after three failed MDD clinical trials for navacaprant. Learn how the company is restructuring to protect its pipeline.

The FDA and UK’s MHRA have launched a new liaison program to accelerate medical innovation and align global drug regulatory standards for improved patient care.

Maharashtra boosts public health with a new rural water policy and the launch of a high-tech Nagpur Medical Cyclotron Project for advanced cancer diagnosis.

Intelligent Bio Solutions begins a vital clinical study to secure FDA clearance, paving the way for a major expansion into the US healthcare market.

The FDA has approved SKINVIVE by JUVÉDERM for neck rejuvenation. Learn how this hyaluronic acid treatment improves skin smoothness and radiance.

The FDA has expanded the use of belzutifan for advanced renal cell carcinoma. Learn about the clinical trial data, HIF-2α inhibition, and patient outcomes.